Commentary on the validation studies of sudden cardiac death and ventricular arrhythmia by Hennessy et al. and Chung et al.

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 6, 2010, Pages 573-575

  Mines, Daniel ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISAPRIDE; NEUROLEPTIC AGENT;

CLINICAL ASSESSMENT; ELECTROCARDIOGRAM; EMERGENCY CARE; HEART VENTRICLE ARRHYTHMIA; HUMAN; NOTE; PRIORITY JOURNAL; RESUSCITATION; RISK FACTOR; SUDDEN DEATH; VALIDATION STUDY;

ALGORITHMS; DEATH, SUDDEN, CARDIAC; EPIDEMIOLOGIC METHODS; HUMANS; PHARMACOEPIDEMIOLOGY; PREDICTIVE VALUE OF TESTS; TACHYCARDIA, VENTRICULAR; UNITED STATES; VALIDATION STUDIES AS TOPIC;

EID: 77953527594     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1913     Document Type: Note

References (17)

1. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98(21): 2334-2351.
2. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2006; 27(17): 2099-2140.
3. Myerburg RJ, Wellens HJ. Epidemiology of cardiac arrest. In Sudden Cardiac Death, Prior SG, Zipes DP (eds). Blackwell Publishing Inc: Malden, MA, 2006; 3-20.
4. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330(26): 1852-1857.
5. Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58(12): 1161-1167. (Pubitemid 33121508)
6. Straus SMJM, Bleumink GS, Dieleman JP, et al. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004; 164(12): 1293-1297.
7. Hennessy S, Bilker WB, Knauss JS, et al. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. Br Med J 2002; 325(7372): 1070.
8. Hennessy S, Leonard CE, Newcomb C, et al. Cisapride and ventricular arrhythmia. Br J Clin Pharmacol 2008; 66(3): 375-385.
9. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001; 345(20): 1473-1482.
10. Bayes de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989; 117(1): 151-159.
11. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360(3): 225-235.
12. Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J 2005; 26(19): 2007-2012.
13. Hennessy S, Leonard CE, Freeman CP, et al. Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf 2010; 19(6): 555-562.
14. Chung CP, Murray KT, Stein CM, Hall K, Ray WA. A computer case definition for sudden cardiac death. Pharmacoepidemiol Drug Saf 2010; 19(6): 563-572.
15. Wysowski DK, Bacsanyi J. Cisapride and fatal arrhythmia. N Engl J Med 1996; 335(4): 290-291.
16. De Bruin ML, van Hemel NM, Leufkens HGM, Hoes AW. Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research. J Clin Epidemiol 2005; 58(12): 1325-1329.
17. ICD-9-CM Official Guidelines for Coding and Reporting, Effective 1 October 2008. Available at: http://www.cdc.gov/nchs/data/icd9/icdguide08.pdf [accessed on 24 November 2009].